Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs
Rhea-AI Summary
Aemetis (NASDAQ: AMTX) said its India subsidiary, Universal Biofuels, secured allocations of approximately $24 million to supply more than 27 million liters of biodiesel to India’s three government-owned OMCs for the period ending March 2026.
Universal Biofuels expanded the Kakinada plant to 80 million gallons/year, uses a proprietary enzymatic low‑carbon process, has operated for 17 years, and is preparing an IPO for a minority stake subject to market conditions.
Positive
- Secured allocations of approximately $24 million to supply >27 million liters of biodiesel
- Kakinada plant capacity expanded to 80 million gallons/year
- Uses a proprietary enzymatic process to produce lower carbon‑intensity biodiesel at reduced cost
- Universal Biofuels has >17 years of operational track record in India
Negative
- Allocations cover a short period ending March 2026, limiting near‑term revenue visibility
- Growth depends on India government achieving a 5% biodiesel blend, a policy target not guaranteed
News Market Reaction
On the day this news was published, AMTX gained 9.68%, reflecting a notable positive market reaction. Argus tracked a peak move of +4.9% during that session. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $10M to the company's valuation, bringing the market cap to $113M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
AMTX gained 1.31% with above-average volume, while peers were mixed: FSI, FF, and ALTO rose between 2–3%, but CMT and FEAM declined. No peers appeared in the momentum scanner and no same-day peer headlines were recorded, pointing to a company-specific catalyst from the India biodiesel allocation and IPO plans.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 30 | Tax credit monetization | Positive | +8.3% | Sale of federal clean energy tax credits generating about $15M net cash. |
| Dec 02 | MVR project permits | Positive | -3.6% | Approval of air permits for MVR project projected to boost cash flow. |
| Nov 14 | Analyst coverage update | Neutral | -1.5% | Coverage note on Q3 2025 performance and biogas growth metrics. |
| Nov 06 | Q3 2025 earnings | Negative | -14.6% | Reported net loss of $23.7M despite India biodiesel and ethanol growth. |
| Oct 31 | Earnings call notice | Neutral | -0.5% | Announcement of upcoming Q3 2025 results conference call and webcast. |
Reactions to news have been mixed: positive tax credit news saw an uptick, while capital project and earnings updates often coincided with share price declines.
Recent news for Aemetis shows a blend of project execution, capital markets activity, and India biodiesel traction. On Dec 30, 2025, the company monetized $17 million of federal tax credits with a +8.33% move. Earlier, a major MVR efficiency project and Q3 2025 earnings highlighted sizable revenue ($59.2 million) but ongoing net losses and high debt, with several of those updates followed by negative price reactions. Today’s India biodiesel allocation and IPO plans extend that India-focused growth narrative.
Market Pulse Summary
The stock moved +9.7% in the session following this news. A strong positive reaction aligns with the clearly incremental nature of the India biodiesel allocation and IPO plans. The company cited roughly $24 million in OMC allocations and capacity of 80 million gallons per year, extending prior India biodiesel commentary. Past news has shown both rallies and selloffs around capital and earnings updates, so position size, project execution, and financing structure around the India subsidiary’s IPO would have remained key watchpoints.
Key Terms
biodiesel technical
renewable natural gas technical
initial public offering (ipo) financial
sustainable aviation fuel technical
AI-generated analysis. Not financial advice.
CUPERTINO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, announced that its Universal Biofuels subsidiary in India secured allocations of approximately
Additional OMC fuel supply orders are expected throughout the year to support the India government’s goal of increasing from a
“Universal Biofuels and other biodiesel producers look forward to continuous support from the government of India to build and expand a healthy biodiesel industry,” stated Sanjeev Duggal, CEO of Universal Biofuels.
“In the past five years, India rapidly grew from about a
The Universal Biofuels subsidiary of Aemetis is one of the largest biodiesel producers in India and has been in operation for more than 17 years. Universal Biofuels has significantly expanded the production capacity of its Kakinada biodiesel plant to 80 million gallons per year, including expansion of its proprietary enzymatic process to produce lower carbon-intensity biodiesel at reduced cost.
Universal Biofuels is exploring opportunities to expand to other locations throughout India, including diversification into the production of other renewable fuels such as dairy biogas, ethanol, and sustainable aviation fuel. To support this growth, Universal Biofuels is preparing to undertake an Initial Public Offering (IPO) for a sale of a minority equity stake to public investors on the India stock exchange, subject to continued favorable market conditions.
About Aemetis
Headquartered in Cupertino, California, Aemetis is a diversified renewable natural gas and biofuels company focused on the development and operation of innovative technologies that lower energy costs and reduce emissions. Founded in 2006, Aemetis is operating and expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates an 80 million gallon per year production facility on the East Coast of India producing high quality biodiesel and refined glycerin. To utilize the byproducts from ethanol production, Aemetis is developing a sustainable aviation fuel plant and a CO2 sequestration project in California. For additional information about Aemetis, please visit www.aemetis.com.
Company Investor Relations
Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com
External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements include, without limitation, projections of financial results; the ability of Universal Biofuels to undertake an IPO; our ability to promote, develop, finance, and construct facilities to produce biodiesel, renewable fuels, and biochemicals; and statements about future market prices and results of government actions. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “view,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Reports on Form 10-K, and in our other filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.